Health
The 3rd International Medical Innovation and Cooperation Forum convenes in Fangchenggang
Enhancing Global Medical Collaboration and Advancing Shared Development through Inclusive Exchange BEIJING, Dec. 4, 2023 /PRNewswire/ -- On 26 November, the 3rd International Medical Innovation and Cooperation Forum was held in Fangchenggang, Guangxi Zhuang Autonomous Region,China. The forum, ...
2023-12-04 08:59
2058
Everest Medicines Announces Investigational New Drug Application Acceptance of Zetomipzomib in China
-- Everest plans to contribute to the ongoing global Phase 2b PALIZADE trial of zetomipzomib in active lupus nephritis – -- Zetomipzomib demonstrated clinically meaningful renal responses with a favorable tolerability profile in an earlier Phase 2 trial -- -- Renal and autoimmune diseases are k...
2023-12-04 08:58
4287
"No Perchlorate, Yes Non-electrolysis"...CJ FNT Introduces Natural Cysteine
FlavorNrich™ MASTER C L-Cysteine gives a healthier alternative to the market with growing demands for natural cysteine with no perchlorates SEOUL, South Korea, Dec. 4, 2023 /PRNewswire/ -- CJ Food & Nutrition Tech (CJ FNT) launched an online campaign showcasing its FlavorNrich™ MASTER C L-Cystei...
2023-12-04 08:00
1809
Media Tour Witnesses Chinese Modernization in Hainan FTP
HAIKOU, China, Dec. 3, 2023 /PRNewswire/ -- From November 27 to December 1, a group made up of more than 60 reporters, overseas communication officers, and social media personalities got their chance to witness the development of the Hainan Free Trade Port (FTP) up close, as they visited key indu...
2023-12-03 16:07
4721
Physical climate risk analysis of over 200 000 hospitals exposes risk of shutdowns from extreme weather
LONDON, Dec. 3, 2023 /PRNewswire/ -- 1 in 12 hospitals around the world could face partial or total shutdown from climate change extreme weather events if countries fail to curb fossil fuel emissions, according to a new report released today by XDI (Cross Dependency Analysis) - a global leader in...
2023-12-03 02:00
2091
The Grand Opening of HKSH's Proton Therapy Centre Marks a Significant Advancement in Precision Cancer Treatment in Hong Kong
HONG KONG, Dec. 2, 2023 /PRNewswire/ -- HKSH Medical Group (HKSH) announced today the grand opening of the HKSH Proton Therapy Centre (the Centre) – the first of its kind inHong Kong. Located at the HKSH Eastern Medical Centre in A Kung Ngam,Shau Kei Wan, the Centre boasts two state-of-the-art tr...
2023-12-02 19:22
3186
The highest incidence of OHCA is at home, with 3 cases of young OHCA occurring at home every week.
Be a brave first responder and save your loved ones' lives. HONG KONG, Dec. 1, 2023 /PRNewswire/ -- SADS HK Foundation (SADS HK) has commissioned the Department of Rehabilitation Sciences of The Hong Kong Polytechnic University (PolyU) to conduct research on the "Out-of-Hospital Cardiac Arrest (...
2023-12-01 21:29
2511
Gates Foundation Announces Partnership with United Arab Emirates to Accelerate Action on Climate and Strengthen Food Systems Through Investment in Agricultural Innovation
Foundation calls for donors to support global agriculture research network CGIAR's 2025-2027 investment need to reach 500 million farmers by 2030 and reduce emissions from the sector by 1 gigaton per year DUBAI, UAE, Dec. 1, 2023 /PRNewswire/ -- The Bill & Melinda Gates Foundation today joined t...
2023-12-01 18:30
2283
The Shanghai Cooperation Organization Traditional Medicine Forum opened
NANCHANG, China, Dec. 1, 2023 /PRNewswire/ -- The Shanghai Cooperation Organization Traditional Medicine Forum opened in Ganjiang New District,Jiangxi Province on November 30, 2023, with the theme of "Inheritance and innovation, unity and cooperation, promoting high-quality development of traditi...
2023-12-01 17:49
2257
Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer
HONG KONG, Germantown, Md. and Suzhou, China, Dec. 1, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company"; stock code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today...
2023-12-01 14:41
2150
Innovent Presents Clinical Data Update of IBI351 (KRAS G12C Inhibitor) Monotherapy in Lung Cancer and Colorectal Cancer at ESMO Asia Congress 2023
ROCKVILLE, Md. and SUZHOU, China, Dec. 1, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...
2023-12-01 12:00
2352
CNN's 'Vital Signs' explores the prospects of phage therapy to treat drug-resistant superbugs
HONG KONG, Dec. 1, 2023 /PRNewswire/ -- Antibiotics have been hailed as a "miracle drug" since the discovery of penicillin in 1928, but now, more bacteria are developing resistance to antibiotics. In 2019, the United Nations estimated nearly 5 million deaths were associated with antimicrobial re...
2023-12-01 11:29
1874
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin and IMCB signed a Memorandum of Understanding to collaborate in the areas of neurometabolism, neurodegeneration, metabolic regulators, and brain health and function. SINGAPORE and DENVER, Dec. 1, 2023 /PRNewswire/ -- Cerecin Inc., a clinical-stage biotechnology company at the forefront o...
2023-12-01 09:34
2554
Everest Medicines Announces Positive Topline Results from Induction Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderate-to-Severe Active Ulcerative Colitis
--Clinically meaningful and statistically significant results demonstrated for primary endpoint and key secondary endpoints for the 12-week induction period-- --Etrasimod was well-tolerated and its safety profile was consistent with prior studies-- --Everest will advance the late-stage study as...
2023-12-01 07:33
2347
Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe
BENGALURU, India, Dec. 1, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris' biosimilars business in 31 European countries has been successfully completed. Following the acquisition of ...
2023-12-01 03:53
1787
Allotex Announces New Investor and Expansion of Production Facilities
BOSTON and MILAN, Dec. 1, 2023 /PRNewswire/ -- Allotex Inc. and SpA, a leading biologics and device company specializing in vision correction therapies, is pleased to announce that Junson Capital has joined its investor syndicate. This additional capital will help support the expansion of the Com...
2023-12-01 03:24
1919
Bushu Pharma Recognized with Frost & Sullivan's 2023 Japan Customer Value Leadership Award for Offering Advanced Pharmaceutical Manufacturing and Robust Supply Chain Solutions
Bushu Pharma produces high-quality pharmaceutical and medical devices with sophisticated quality control and supply chain management support that prioritizes customer value. SAN ANTONIO, Nov. 30, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the contract development and manufacturing...
2023-11-30 22:30
1604
Argon Medical Launches Kodiak™ Dual Port Coaxial Introducer Kit for Complex Vascular Procedures
PLANO, Texas, Nov. 30, 2023 /PRNewswire/ -- Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, announced the launch of the Kodiak™ Dual Port Coaxial Introducer Kit for precise and streamlined intro...
2023-11-30 22:22
1827
NCCN and SLACOM Host International Symposium to Improve Breast Cancer Care in Latin America
Experts from across Latin America explore how to improve access to recommended treatment practices based on the latest international guidelines. BUENOS AIRES, Argentina and PLYMOUTH MEETING, Pa., Nov. 30, 2023 /PRNewswire/ -- Today the Latin American and Caribbean Society of Medical Oncology (SLA...
2023-11-30 22:04
1306
Innovent's MSCI ESG Rating Upgraded to A
ROCKVILLE, Md. and SUZHOU, China, Nov. 30, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2023-11-30 21:37
7255
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
9173
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7712